Literature DB >> 24710804

Evaluation of mild cognitive impairment subtypes in Parkinson's disease.

Brenna A Cholerton1, Cyrus P Zabetian, Jia Y Wan, Thomas J Montine, Joseph F Quinn, Ignacio F Mata, Kathryn A Chung, Amie Peterson, Alberto J Espay, Fredy J Revilla, Johnna Devoto, G Stennis Watson, Shu-Ching Hu, James B Leverenz, Karen L Edwards.   

Abstract

Mild cognitive impairment in Parkinson's disease (PD-MCI) is common and increases the risk for dementia. Establishing distinct PD-MCI cognitive subtypes could be valuable for eventually predicting those most likely to convert to dementia. However, the study of PD-MCI subtypes has not yielded consistent results among cohorts. To determine whether there are distinct cognitive subtypes among participants diagnosed with PD-MCI in the Pacific Northwest Udall Center Clinical Consortium, we cognitively subtyped 95 patients with PD-MCI, using the Movement Disorders Society Task Force diagnostic guidelines. Psychometric test scores were then subjected to principle components factor analysis to determine whether similar cognitive subgroups could be identified using statistical methodology. Multiple-domain PD-MCI was diagnosed in 95% of the sample, and a range of cognitive impairments were noted. Factor analysis yielded seven factors and demonstrated overlap of phonemic verbal fluency on two factors, as well as the loading of verbal fluency on the same factor as a visuospatial measure; however, these factors did not partition the sample into distinct cognitive subtypes. Separation of cognitive subtypes based on the current PD-MCI criteria, or via statistical methods, may not provide sufficient information to describe distinct PD groups. Future efforts to validate the PD-MCI criteria and identify combinations of genetic or other risk factors for cognitive impairment are warranted.
© 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson disease; cognition; mild cognitive impairment; neuropsychological assessment

Mesh:

Year:  2014        PMID: 24710804      PMCID: PMC4013249          DOI: 10.1002/mds.25875

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  39 in total

Review 1.  Mild cognitive impairment in Parkinson's disease.

Authors:  J G Goldman; I Litvan
Journal:  Minerva Med       Date:  2011-12       Impact factor: 4.806

2.  Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.

Authors:  Jennifer G Goldman; Samantha Holden; Bryan Bernard; Bichun Ouyang; Christopher G Goetz; Glenn T Stebbins
Journal:  Mov Disord       Date:  2013-10-09       Impact factor: 10.338

3.  Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease.

Authors:  Roy N Alcalay; Helen Mejia-Santana; Ming X Tang; Brian Rakitin; Llency Rosado; Barbara Ross; Miguel Verbitsky; Sergey Kisselev; Elan D Louis; Cynthia L Comella; Amy Colcher; Danna Jennings; Martha A Nance; Susan Bressman; William K Scott; Caroline Tanner; Susan F Mickel; Howard F Andrews; Cheryl H Waters; Stanley Fahn; Lucien J Cote; Steven J Frucht; Blair Ford; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald Pfeiffer; Laura Marsh; Bradley Hiner; Andrew Siderowf; Ruth Ottman; Lorraine N Clark; Karen S Marder; Elise Caccappolo
Journal:  J Clin Exp Neuropsychol       Date:  2010-02-24       Impact factor: 2.475

Review 4.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

5.  Longitudinal changes in cognition in Parkinson's disease with and without dementia.

Authors:  David K Johnson; James E Galvin
Journal:  Dement Geriatr Cogn Disord       Date:  2011-01-18       Impact factor: 2.959

6.  Cognitive impairments in progression of Parkinson's disease.

Authors:  D A Stepkina; V V Zakharov; N N Yakhno
Journal:  Neurosci Behav Physiol       Date:  2010-01

7.  Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease.

Authors:  William Reginold; Sarah Duff-Canning; Christopher Meaney; Melissa J Armstrong; Susan Fox; Brandon Rothberg; Cindy Zadikoff; Nancy Kennedy; David Gill; Paul Eslinger; Fred Marshall; Mark Mapstone; Kelvin L Chou; Carol Persad; Irene Litvan; Benjamin Mast; David Tang-Wai; Anthony E Lang; Connie Marras
Journal:  Dement Geriatr Cogn Disord       Date:  2013-06-15       Impact factor: 2.959

8.  APOE ε4 increases risk for dementia in pure synucleinopathies.

Authors:  Debby Tsuang; James B Leverenz; Oscar L Lopez; Ronald L Hamilton; David A Bennett; Julie A Schneider; Aron S Buchman; Eric B Larson; Paul K Crane; Jeffrey A Kaye; Patricia Kramer; Randy Woltjer; John Q Trojanowski; Daniel Weintraub; Alice S Chen-Plotkin; David J Irwin; Jacqueline Rick; Gerard D Schellenberg; G Stennis Watson; Walter Kukull; Peter T Nelson; Gregory A Jicha; Janna H Neltner; Doug Galasko; Eliezer Masliah; Joseph F Quinn; Kathryn A Chung; Dora Yearout; Ignacio F Mata; Jia Y Wan; Karen L Edwards; Thomas J Montine; Cyrus P Zabetian
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

9.  Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study.

Authors:  Yaroslau Compta; Joana B Pereira; Jose Ríos; Naroa Ibarretxe-Bilbao; Carme Junqué; Núria Bargalló; Ana Cámara; Mariateresa Buongiorno; Manel Fernández; Claustre Pont-Sunyer; Maria J Martí
Journal:  Parkinsonism Relat Disord       Date:  2013-05-03       Impact factor: 4.891

10.  The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.

Authors:  Caroline H Williams-Gray; Sarah L Mason; Jonathan R Evans; Thomas Foltynie; Carol Brayne; Trevor W Robbins; Roger A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-06-18       Impact factor: 10.154

View more
  27 in total

Review 1.  Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.

Authors:  Jennifer G Goldman; Neelum T Aggarwal; Cynthia D Schroeder
Journal:  Neurodegener Dis Manag       Date:  2015-10-30

2.  Group comparison of spatiotemporal dynamics of intrinsic networks in Parkinson's disease.

Authors:  Tara M Madhyastha; Mary K Askren; Jing Zhang; James B Leverenz; Thomas J Montine; Thomas J Grabowski
Journal:  Brain       Date:  2015-07-14       Impact factor: 13.501

3.  Homocysteine and cognitive function in Parkinson's disease.

Authors:  Nicole Licking; Charles Murchison; Brenna Cholerton; Cyrus P Zabetian; Shu-Ching Hu; Thomas J Montine; Amie L Peterson-Hiller; Kathryn A Chung; Karen Edwards; James B Leverenz; Joseph F Quinn
Journal:  Parkinsonism Relat Disord       Date:  2017-08-09       Impact factor: 4.891

Review 4.  Integrating Patient Concerns into Parkinson's Disease Management.

Authors:  Shen-Yang Lim; Ai Huey Tan; Susan H Fox; Andrew H Evans; Soon Chai Low
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

5.  Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.

Authors:  Lilah M Besser; Irene Litvan; Sarah E Monsell; Charles Mock; Sandra Weintraub; Xiao-Hua Zhou; Walter Kukull
Journal:  Parkinsonism Relat Disord       Date:  2016-04-09       Impact factor: 4.891

6.  Onset of Mild Cognitive Impairment in Parkinson Disease.

Authors:  David K Johnson; Zachary Langford; Mauricio Garnier-Villarreal; John C Morris; James E Galvin
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Apr-Jun       Impact factor: 2.703

7.  Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis.

Authors:  Laura Brennan; Kathryn M Devlin; Sharon X Xie; Dawn Mechanic-Hamilton; Baochan Tran; Howard H Hurtig; Alice Chen-Plotkin; Lama M Chahine; James F Morley; John E Duda; David R Roalf; Nabila Dahodwala; Jacqueline Rick; John Q Trojanowski; Paul J Moberg; Daniel Weintraub
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

8.  Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson's disease.

Authors:  Kazuya Kawabata; Hirohisa Watanabe; Kazuhiro Hara; Epifanio Bagarinao; Noritaka Yoneyama; Aya Ogura; Kazunori Imai; Michihito Masuda; Takamasa Yokoi; Reiko Ohdake; Yasuhiro Tanaka; Takashi Tsuboi; Tomohiko Nakamura; Masaaki Hirayama; Mizuki Ito; Naoki Atsuta; Satoshi Maesawa; Shinji Naganawa; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

9.  White Matter Lesions in Mild Cognitive Impairment and Idiopathic Parkinson's Disease: Multimodal Advanced MRI and Cognitive Associations.

Authors:  Swati Rane; Julia Owen; Daniel S Hippe; Brenna Cholerton; Cyrus P Zabetian; Tom Montine; Thomas J Grabowski
Journal:  J Neuroimaging       Date:  2020-09-16       Impact factor: 2.486

10.  Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS).

Authors:  Roberto Monastero; Calogero Edoardo Cicero; Roberta Baschi; Marco Davì; Antonina Luca; Vincenzo Restivo; Chiara Zangara; Brigida Fierro; Mario Zappia; Alessandra Nicoletti
Journal:  J Neurol       Date:  2018-02-24       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.